/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.03%
Natural Gas
-3.48%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.86%
VIX
N/A
Economic Calendar
EUR/USD
-0.03%
Natural Gas
-3.48%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.86%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
China Caixin Manufacturing PMI Returns to Expansion But Labor Market Woes Linger
5 minutes ago
Apple, Amazon, and Intel Earnings: iPhone, Cloud, and AI Drive Growth Amid Key Challenges
about 5 hours ago
EIA Natural Gas Storage Build Of +78 Bcf Misses Analyst Estimates
about 10 hours ago
AI Powers Microsoft’s Growth; Meta, Starbucks Tackle User and Sales Challenges
1 day ago
Crude Inventories Declined By 0.5 Million Barrels
1 day ago
U.S. Q3 GDP Grows 2.8%, Misses Forecast as Housing and Income Growth Slow
1 day ago
Gold, Silver, EUR/USD Technical Analysis After US Core PCE Inflation Data
about 1 hour ago
Japanese Yen and Australian Dollar News: Japan and China’s PMIs in Focus
about 2 hours ago
3 Solana Memecoins to Watch ahead of US Elections: WIF, BONK, BOME Price Analysis
about 4 hours ago
BNB Price Predicted to Retake $600 as Changpeng Zhao Weighs Binance Return
about 5 hours ago
Gold Price Forecast: Faces Correction Risks After Record High Reversal
about 6 hours ago
Crude Oil Price Forecast: Gains Momentum, Eyes Key Resistance Levels Above 71.83
about 6 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
PMCB
profile
PharmaCyte Biotech Inc
Follow
PMCB
(
Nasdaq - US
)
Closed
1.83
-0.04 (-2.41%)
in
:
usd
•
As of: Oct 31, 2024 15:59
UTC -4
Open
1.87
High
1.95
Low
1.81
Overview
Profile
Financials
Advanced Chart
History
Earnings
About
PharmaCyte Biotech Inc
CEO
Joshua N. Silverman
Headquarters
3960 howard hughes parkway, suite 500
las vegas, nv 89169, united states
Auditor
Marcum LLP
Employees
2
Share Holders
1,400
Website
www.PharmaCyte.com
Industry
pharmaceuticals other
Sector
health technology
Company Overview
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.
PharmaCyte Biotech Inc
Statistics
Valuation Measures
Market Capitalization
2
14.02M
Enterprise Value
-18.62M
Enterprise Value/EBITDA
(ttm)
2.41
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
0.31
Price to Sales
(ttm)
N/A
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
0.00%
Operating Margin
(ttm)
N/A
Profit Margin
(ttm)
0.00%
Return on Equity
(ttm)
1.38%
Return on Invested Capital
(ttm)
59.58%
Return on Assets
(ttm)
0.71%
Income Statement
Revenue
(ttm)
0.00
Revenue Per Share
(ttm)
0.00
Gross Profit
(ttm)
0.00
EBITDA
(ttm)
3
-7.71M
Net Income Avi to Common
(ttm)
4.50M
Diluted EPS
(ttm)
0.66
Share Statistics
Beta (5Y Monthly)
-0.21
52-Week Change
-13.92%
S&P500 52-Week Change
36.04%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
7.68M
Dividend Yield
0.00%
Float
4
7.60M
%
Held by Insiders
1.03%
%
Held by Institutions
34.24%
Balance Sheet
Total Cash
(mrq)
32.64M
Total Cash Per Share
(mrq)
4.25
Total Debt
(mrq)
0.00
Total Debt/Equity
(mrq)
0.00%
Current Ratio
(mrq)
4.40%
Quick Ratio
(mrq)
4.40%
Book Value Per Share
(mrq)
6.18
Cash Flow
Operating Cash Flow Per Share
(ytd)
-0.05
Free Cash Flow
(ytd)
-373.30K
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker